Provided by Tiger Fintech (Singapore) Pte. Ltd.

Accolade, Inc.

7.02
+0.0000
Volume:- -
Turnover:- -
Market Cap:575.59M
PE:-3.04
High:7.02
Open:7.02
Low:7.02
Close:7.02
Loading ...

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia

Benzinga
·
19 Jan

Accolade’s Merger Agreement with Transcarent Poses Strategic and Financial Risks

TIPRANKS
·
14 Jan

Stephens Downgrades Accolade to Equalweight From Overweight, Trims Price Target to $7.03 From $8

MT Newswires Live
·
13 Jan

Accolade Inc : Truist Securities Cuts Target Price to $7.03 From $7.5

THOMSON REUTERS
·
13 Jan

Accolade downgraded to Equal Weight from Overweight at Stephens

TIPRANKS
·
11 Jan

Accolade (ACCD) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
11 Jan

Accolade: Fiscal Q3 Earnings Snapshot

Associated Press Finance
·
10 Jan

Truist Securities Downgrades Accolade to Hold From Buy

MT Newswires Live
·
10 Jan

U.S. RESEARCH ROUNDUP-Antero Resources, IGM Biosciences, Lennar

Reuters
·
10 Jan

Accolade Inc : Raymond James Cuts to Market Perform From Outperform

THOMSON REUTERS
·
09 Jan

Accolade Inc : Stifel Cuts to Hold From Buy

THOMSON REUTERS
·
09 Jan

Leerink Partners Downgrades Accolade to Market Perform From Outperform, Adjusts Price Target to $7.03 From $9.50

MT Newswires Live
·
09 Jan

Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Accolade (ACCD)

TIPRANKS
·
09 Jan

Accolade (ACCD) Receives a Hold from Wells Fargo

TIPRANKS
·
09 Jan

Accolade Inc : Canaccord Genuity Cuts to Hold From Buy

THOMSON REUTERS
·
09 Jan

U.S. RESEARCH ROUNDUP-Accolade, Costco Wholesale, RH

Reuters
·
09 Jan

Accolade Inc : Needham Cuts to Hold From Buy

THOMSON REUTERS
·
09 Jan

Hold Rating on Accolade: Evaluating Transcarent’s Acquisition Amidst Market Challenges

TIPRANKS
·
09 Jan

Accolade Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
09 Jan

Accolade (ACCD) was downgraded to a Hold Rating at Needham

TIPRANKS
·
09 Jan